Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Acute Ischemic Stroke peptide trials
4 selected ClinicalTrials.gov records carrying the official condition label Acute Ischemic Stroke. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
4 selected records.
3 profiles.
2025–2026 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 81 selected PubMed records and 17 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Acute Ischemic Stroke unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT03480698
PeptideScanner retained ClinicalTrials.gov record NCT03480698 at 2026-11-16T17:33:14.861Z. Its registry update date was 2025-02-25, and PeptideScanner's reviewed identity mapping was cerebrolysin.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- February 25, 2025
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT06339411
PeptideScanner retained ClinicalTrials.gov record NCT06339411 at 2026-11-16T17:33:14.861Z. Its registry update date was 2026-08-11, and PeptideScanner's reviewed identity mapping was cerebrolysin.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- August 11, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT07495722
PeptideScanner retained ClinicalTrials.gov record NCT07495722 at 2026-11-16T01:37:14.654Z. Its registry update date was 2026-04-29, and PeptideScanner's reviewed identity mapping was pegcetacoplan.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- April 29, 2026
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Cerebrolysin · 2026-08-11
ClinicalTrials.gov record NCT06339411
Not yet recruiting at the retained observation.
Open attributed record →Pegcetacoplan · 2026-04-29
ClinicalTrials.gov record NCT07495722
Not yet recruiting at the retained observation.
Open attributed record →Cerebrolysin · 2025-02-25
ClinicalTrials.gov record NCT03480698
Completed at the retained observation.
Open attributed record →Eptifibatide · 2025-02-07
ClinicalTrials.gov record NCT03735979
Completed at the retained observation.
Open attributed record →